Amiloride-sensitive Na+ channels in pelvic uroepithelium involved in renal sensory receptor activation.
Stretching the renal pelvic wall increases ipsilateral afferent renal nerve activity (ARNA). This response is enhanced by inhibiting Na+-K+-ATPase with ouabain, suggesting a modulatory role for intracellular Na+ in the activation of mechanosensitive neurons. The messenger RNA for alpha-, beta-, and gamma-subunits of epithelial Na+ channels (ENaC) is found in collecting duct cells. Because ENaC subunits show homology with genes involved in mechanosensation, we examined whether ENaC mRNA could be found in the pelvic wall and whether the ARNA response to increased renal pelvic pressure was modulated by blockers of the Na+ channel. alpha-, beta-, and gamma-subunits are present in the pelvis. The messenger RNA for the beta- and gamma-subunits is readily detected by in situ hybridization throughout the uroepithelium. The ARNA response to increased renal pelvic pressure was reduced by 53 +/- 10% and 40 +/- 10% (P < 0.01) by renal pelvic perfusion with the inhibitors amiloride and benzamil, respectively. Amiloride inhibited the ouabain-induced enhancement of the ARNA response to increased renal pelvic pressure. The magnitude of this inhibition was inversely correlated with the magnitude of the amiloride-mediated blockade of the ARNA response to increased renal pelvic pressure (P < 0.001). Amiloride also reduced the ARNA response to renal pelvic administration of substance P, a mediator of the ARNA response to increased renal pelvic pressure. We conclude that the ENaC complex in the pelvic uroepithelium participates in the activation of renal pelvic mechanosensitive neurons.
Kopp
U C
UC
Department of Internal Medicine, Department of Veterans Affairs Medical Center and University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
Matsushita
K
K
Sigmund
R D
RD
Smith
L A
LA
Watanabe
S
S
Stokes
J B
JB
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology*; D017403:In Situ Hybridization; D007668:Kidney / Q000294:innervation*; D007682:Kidney Pelvis / Q000378:metabolism* / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology; D010042:Ouabain / Q000494:pharmacology; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D011984:Sensory Receptor Cells / Q000502:physiology*; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D013373:Substance P / Q000494:pharmacology; D019459:Urothelium / Q000378:metabolism*
D004232:Diuretics; D015222:Sodium Channels; C013407:benzamil; D013373:Substance P; D010042:Ouabain; D000584:Amiloride; D002211:Capsaicin